Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2006

Conditions
Hypercholesterolaemia
Interventions
PROCEDURE

Echographic measurements

PROCEDURE

Blood samples

Trial Locations (69)

1030

Pfizer Investigational Site, Brussels

1050

Pfizer Investigational Site, Brussels

1090

Pfizer Investigational Site, Brussels

1180

Pfizer Investigational Site, Brussels

1190

Pfizer Investigational Site, Brussels

1630

Pfizer Investigational Site, Linkebeek

5400

Pfizer Investigational Site, Nancy

6222

Pfizer Investigational Site, VE Maastricht

6291

Pfizer Investigational Site, EN Vaals

6367

Pfizer Investigational Site, ED Voerendaal

8700

Pfizer Investigational Site, Tielt

9000

Pfizer Investigational Site, Ghent

9032

Pfizer Investigational Site, Wondelgem

9051

Pfizer Investigational Site, Afsnee GENT

9100

Pfizer Investigational Site, Sint-Niklaas

9230

Pfizer Investigational Site, Wetteren

9940

Pfizer Investigational Site, Ertvelde

9960

Pfizer Investigational Site, Assenede

54000

Pfizer Investigational Site, Nancy

54100

Pfizer Investigational Site, Nancy

54130

Pfizer Investigational Site, Saint-Max

54170

Pfizer Investigational Site, Colombey-les-Belles

54200

Pfizer Investigational Site, Toul

54390

Pfizer Investigational Site, Frouard

54420

Pfizer Investigational Site, Pulnoy

54500

Pfizer Investigational Site, Vandœuvre-lès-Nancy

54520

Pfizer Investigational Site, Laxou

54660

Pfizer Investigational Site, Moûtiers

54700

Pfizer Investigational Site, Pont-à-Mousson

54800

Pfizer Investigational Site, Mars-la-Tour

55000

Pfizer Investigational Site, Bar-le-Duc

55100

Pfizer Investigational Site, Verdun

55140

Pfizer Investigational Site, Sauvigny

55170

Pfizer Investigational Site, Ancerville

57000

Pfizer Investigational Site, Metz

57180

Pfizer Investigational Site, Terville

57320

Pfizer Investigational Site, Bouzonville

57685

Pfizer Investigational Site, Augny

67000

Pfizer Investigational Site, Strasbourg

67200

Pfizer Investigational Site, Strasbourg

67201

Pfizer Investigational Site, Eckbolsheim

67204

Pfizer Investigational Site, Achenheim

67380

Pfizer Investigational Site, Lingolsheim

67460

Pfizer Investigational Site, Souffelweyersheim

67500

Pfizer Investigational Site, Haguenau

67530

Pfizer Investigational Site, Bœrsch

67760

Pfizer Investigational Site, Gambsheim

67840

Pfizer Investigational Site, Kilstett

75008

Pfizer Investigational Site, Paris

75012

Pfizer Investigational Site, Paris

75015

Pfizer Investigational Site, Paris

75016

Pfizer Investigational Site, Paris

75017

Pfizer Investigational Site, Paris

76100

Pfizer Investigational Site, Rouen

76120

Pfizer Investigational Site, Le Grand-Quevilly

76240

Pfizer Investigational Site, Le Mesnil-Esnard

76308

Pfizer Investigational Site, Sotteville-lès-Rouen

77190

Pfizer Investigational Site, Dammarie-les-Lys

88460

Pfizer Investigational Site, Docelles

91150

Pfizer Investigational Site, Étampes

91310

Pfizer Investigational Site, Leuville-sur-Orge

Pfizer Investigational Site, Longpont-sur-Orge

91360

Pfizer Investigational Site, Epinay S/orge

91410

Pfizer Investigational Site, Dourdan

91600

Pfizer Investigational Site, Savigny-sur-Orge

91700

Pfizer Investigational Site, Sainte-Geneviève-des-Bois

92220

Pfizer Investigational Site, Bois-Colombes

94300

Pfizer Investigational Site, Vincennes

94470

Pfizer Investigational Site, Boissy-Saint-Léger

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00163163 - Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women | Biotech Hunter | Biotech Hunter